Skip to content
DraconiticResearch
Search Sources API
189,280 studies31 sourcesUpdated 8 min ago
Peer-reviewedCC BY 4.0Frontiers in Cardiovascular Medicine

The emerging discipline has emerged: cardio-oncology as a medical specialty

  • Yohannes T. Ghebre1,2,3
  • Derek R. Shyr1
  • Pius S. Fasinu4
4 affiliations
  1. 1Marnix E. Heersink School of Medicine, The University of Alabama at Birmingham
  2. 2Department of Radiation Oncology, The University of Texas Health Science Center at San Antonio
  3. 3Mays Cancer Center, The University of Texas Health Science Center at San Antonio
  4. 4Department of Medical Education, The University of Alabama at Birmingham Heersink School of Medicine
Open at sourcePDFDOICite

Abstract

Remarkable advances in cancer therapeutics have transformed many malignancies into chronic, manageable diseases, creating an unprecedented population of long-term cancer survivors. However, these gains have been accompanied by a growing burden of cardiovascular disease resulting from both cancer therapies and shared biological mechanisms between cancer and cardiovascular disease. Cardio-oncology has emerged to address this challenge by integrating cardiovascular prevention, surveillance, diagnosis, and treatment throughout the range of cancer care. What began as a consultative niche focused largely on anthracycline-induced cardiomyopathy has rapidly evolved into a multidisciplinary specialty supported by international guidelines, dedicated clinical programs, structured surveillance strategies, specialized training initiatives, and expanding research networks. This perspective argues that cardio-oncology has crossed the threshold from an emerging field to an established medical discipline. We discuss the milestones that define its maturation, the challenges that remain, and the priorities required to ensure equitable implementation worldwide.

Related

  1. Improving Awareness of Oman Medical Specialty Board Training Bylaws Among First-Year Pediatric Residents Using a Flipped Classroom Intervention: A Quality Improvement Project
    Saniya Al Husaini, Abdul Hamid Al Hinai, Majan Al Siyabi +2
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Factors associated with choosing diagnostic radiology as a future specialty among Palestinian medical students: a multicenter cross-sectional study
    Ibrahim Ammar AbuAttallah, Jana A Qrareya, Reem S Adawi +2
    PLOS OnePeer-reviewedCC BYFull textMedical imaging & radiologySurgery & anaesthesiaPLOSEurope PMCPMC
  3. The Hidden Burden of Cancer-Associated Venous Thromboembolism ― An Emerging Challenge in Cardio-Oncology ―
    Jiro Sakamoto
    Circulation JournalPeer-reviewedCC BY-NC-NDFull textCardiovascular medicineJ-STAGE
  4. Exercise oncology and tumor sterol metabolism: An emerging mechanistic frontier
    Marc Poirot, Philippe de Médina, Sandrine Silvente-Poirot
    Journal of Sport and Health SciencePeer-reviewedCC BY-NC-ND 4.0Full textGeneral biochemistryCell biologyHAL
  5. Characterization of prolonged hospital stays on a Medical Oncology Department in Portugal
    Teresa Lopes Bruno, Fernando Kellen, Sara Magno +1
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textGeneral medicineCrossref

Cite

BibTeXRIS
BibTeX
@article{ghebre2026emerging,
  title = {{The emerging discipline has emerged: cardio-oncology as a medical specialty}},
  author = {Yohannes T. Ghebre and Derek R. Shyr and Pius S. Fasinu},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2026},
  month = oct,
  doi = {10.3389/fcvm.2026.1954059},
  url = {https://www.frontiersin.org/articles/10.3389/fcvm.2026.1954059/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - The emerging discipline has emerged: cardio-oncology as a medical specialty
AU  - Yohannes T. Ghebre
AU  - Derek R. Shyr
AU  - Pius S. Fasinu
PY  - 2026
DA  - 2026/10/28
JO  - Frontiers in Cardiovascular Medicine
DO  - 10.3389/fcvm.2026.1954059
UR  - https://www.frontiersin.org/articles/10.3389/fcvm.2026.1954059/full
AB  - Remarkable advances in cancer therapeutics have transformed many malignancies into chronic, manageable diseases, creating an unprecedented population of long-term cancer survivors. However, these gains have been accompanied by a growing burden of cardiovascular disease resulting from both cancer therapies and shared biological mechanisms between cancer and cardiovascular disease. Cardio-oncology has emerged to address this challenge by integrating cardiovascular prevention, surveillance, diagnosis, and treatment throughout the range of cancer care. What began as a consultative niche focused largely on anthracycline-induced cardiomyopathy has rapidly evolved into a multidisciplinary specialty supported by international guidelines, dedicated clinical programs, structured surveillance strategies, specialized training initiatives, and expanding research networks. This perspective argues that cardio-oncology has crossed the threshold from an emerging field to an established medical discipline. We discuss the milestones that define its maturation, the challenges that remain, and the priorities required to ensure equitable implementation worldwide.
SN  - 2297-055X
ER  -